Word Count: Main text (excluding abstract and methods) 2,912. Abstract 114 words. Abstract 4 6 4 7 Circulating cytokines and growth factors are regulators of inflammation and have been implicated 4 8 in autoimmune and metabolic diseases. In this genome-wide association study (GWAS) up to 4 9 7 4 often share common pathology, the indications of approved drugs can often be expanded 5 . For 7 5 example, a tumor necrosis factor alpha (TNF-α) antibody adalimumab has FDA approval for 7 6 rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis and 7 7
Results from the random effect meta-analysis for heterogenic single nucleotide polymorphisms 1 0 4 (SNPs) (HetPval < 0.1) are reported in Supplementary Table 2 . Effect estimates from the random 1 0 5 effect models were coherent with effect estimates from the fixed effect models; however, for ten of the heterogenic loci the P-value did not reach the genome-wide significance (1.2x10 -9 ) with the leukocytes from MEP1B-/-mice have been shown to have impaired migration in response to 1 1 5 monocyte chemotactic protein-1 (MCP1) and macrophage inflammatory protein-1α (MIP1a) 10 .
Additional low-frequency variants with large effects included rs141053179 (β=1.1 SD) for 1 1 7
interferon gamma-induced protein 10 (IP10), rs116924815 (β=0.61 SD) for stem cell growth factor 1 1 8 beta (SCGFb), and rs4778636 (β=-0.73 SD) for interleukin-16 (IL16). Novel common variants 1 1 9
(MAF>5%) with large effects (β up to -0.49) included rs2070074 and rs13412535 for Cutaneous
T-cell attracting (CTACK) and platelet derived growth factor BB (PDGFbb). In addition to 1 2 1 discovering new loci, our results confirmed associations for 10 genome-wide significant loci 1 2 2 previously identified. These include two loci with interleukin-18 (IL18) concentration (2p22.3 and 1 2 3 11q23.1) 11, 12 . We also replicated two loci previously associated with vascular endothelial growth 1 2 4 factor (VEGF; 6p21.1 and 9p24.2) 13 and one additional locus previously associated with monocyte 1 2 5 chemotactic protein-1 (MCP1; 1q23.2) 14 . Manhattan plots, QQ-plots and detailed plots from with vascular endothelial growth factor (VEGF), the association signal was narrow and hereby rs6921438, the subsequent lead SNP was rs12214617 which is located 46kB from rs6921438.
According to Ensembl, the secondary association signal rs12214617 is located on the promoter reference. For some of the genetic loci associated with cytokines the association signal is much
wider, which makes the identification of the potential functional variant more challenging. For instance, the signal spans approximately 600kB for IL18-associated 2p22.3. The association peak 1 3 8
for PDGFbb in 2q36.1 is mainly formed by only two variants (rs13412535 and rs68066031) in 1 3 9 strong linkage disequilibrium. However, after conditioning on rs13412535 the peak is lost.
According to Ensembl, the rs13412535 is located in a transcription factor binding cite and DNase Four of the identified loci were associated with the concentration of more than one cytokine is not directly mediated via any of the three pertinent cytokines, but rather through altering binding 1 4 9
of these cytokines to the DARC receptor ( Fig. 2a) . Similarly, the effect of rs2228467 at 3p22.1 on 1 5 0 eotaxin and MCP1 appears to be mediated via chemokine-binding protein 2 (CCBP2), rather than 1 5 1 directly via eotaxin or MCP1 (Fig. 2b) . In contrast, a variant at 6p21.1 (rs6921438) is associated IL12p70, IL7, IL10, and IL13 ( Fig. 2c-d) . Variants in 10q21.3 were associated with VEGF and 1 5 9
IL12p70. The lead SNP within this locus is rs10761731, which has the smallest association test P- To assess whether the genetic loci identified harbor additional independent variants, we performed ( Supplementary Table 5 ). These five statistically independent variants together explained 34% of concentration. In addition, GROa was shown to be under a strong genetic control as the identified 1 7 2
SNPs explained 10% of the circulating GROa variance. To further elucidate the molecular mechanisms underlying the genome-wide association peaks, we 1 7 5
performed peripheral blood expression quantitative trait loci (eQTL) analyses for lead SNPs. Transcriptomic data were meta-analyzed for 2,177 participants from YFS and FINRISK2007. These analyses identified 26 significant eQTLs for 15 SNPs. The eQTLs for SNPs in Table 1 concentration may therefore be a compensatory mechanism to account for missing circulating IL16. The genome-wide association of rs4778636 with circulating IL16 confirms results from a small 200kB away from a cluster of cytokine-coding genes in 17q21. According to our results, the 1 8 8
MIP1b-associatied SNP is an eQTL for four of the genes (CCL4L1, CCL4L2, CCL3L1, CCL3L3) 1 8 9
belonging to this cluster. The variant which was associated with concentration of PDGFbb and 1 9 0 resided at a transcription factor binding site (rs13412535) was associated with expression of 1 9 1 SERPINE2. Interestingly, rs13412535 is located within an intron of SERPINE2 within the gene Novel drug targets for celiac disease and Behcet's disease and wider indication for IL2ra To bridge the connection between the cytokine traits and disease, we searched the GWAS catalogue 1 9 7
for SNP-trait and SNP-disease associations within a 1Mb window from cytokine lead SNPs 20 1 9 8 (www.genome.gov/gwastudies). The search window approach was selected since many GWASes 1 9 9
for the complex diseases have been conducted with HapMap2 and therefore missed variants present associated with disease status are listed in Table 3 ; the corresponding associations for cytokine- linked SNPs previously associated with quantitative traits are listed in Supplementary Table 8 .
The circulating interleukin-2 receptor alpha subunit (IL2ra) increasing variant (rs12722489-C) has 2 0 4
previously been shown to increase the risk for Crohn's disease and multiple sclerosis 1,22 . The previously been linked to increased risk for ulcerative colitis 23 . In addition, both cytokines have 2 0 7 been shown to be increased in patients with an inflammatory bowel disease 24,25 . These results link 2 0 8 the VEGF cascade depicted in Figure 2C to inflammatory bowel disease. Variant rs7616215-T here 2 0 9 associated with increased concentration of MIP1b has previously been shown to decrease the risk 2 1 0
for Behcet's disease 26 . In addition to disease associations, the cytokine loci identified here were 2 1 1 linked to 15 different molecular traits. For example, rs2251746 located at 1q23.2 within FCER1A 2 1 2 and previously linked to IgE concentration was here associated with circulating concentration of 2 1 3
GROa and MCP1. This study identified 27 (17 novel) genetic loci contributing to circulating concentration of one or 2 1 6 more cytokines in the general population. In three cases, the genomic analyses linked the genetic 2 1 7 variant via mRNA to the circulating cytokine concentration, and therefore likely pinpointed the 2 1 8 causal gene. Genetic evidence identify a potentially novel drug target for treatment of Behcet's 2 1 9
disease and celiac disease, since variants associated with decreased concentration of MIP1b in this 2 2 0 study have previously been linked with increased risk of these diseases 26, 27 . Furthermore, our results 2 2 1 point to a novel indication for IL2ra-antagonist, since the IL2-ra variant identified in our study has 2 2 2 previously been associated with increased risk of Crohn's disease. The IL2ra-targeting antibody 2 2 3 daclizumab reduces annualized relapse rate in multiple sclerosis patients by 50% compared to 2 2 4 placebo 28 . Our results suggest that daclizumab might be beneficial for patients with Crohn's disease 2 2 5 as well. The association of one locus to multiple circulating cytokines might help to understand clustering of 2 2 7 autoimmune diseases. For example, a person with rheumatoid arthritis has more than 160-fold risk here associated with increased circulating VEGF and shown to have a causal cascade effect on IL7, 2 3 0 IL10, IL13 and IL12p70 ( Fig 2C-D) . Axitinib, a VEGF-receptor inhibitor, has been shown to 2 3 1 reduce IL12p70 production in cultured monocyte-derived dendritic cells 29 , which support our 2 3 2 findings. Furthermore, VEGFA-transcription follows the same temporal pattern with IL7 2 3 3 transcription during wound healing, and it has been suggested that the secretion of these two 2 3 4 cytokines might be connected by the same pathway 30 . These results from prior functional studies 2 3 5 support our genetic evidence in humans that VEGF causally regulates secretion of IL7, IL10, IL13 and IL12p70 under normal physiological conditions in healthy individuals. VEGF contributes to 2 3 7 pathogenesis of asthma by stimulating angiogenesis, edema, inflammation and airway remodeling. These effects are partly mediated via VEGF-mediated upregulation of IL13 31 . Most importantly, by have been shown to release significant amounts of MCP1 from DARC, and thus affect the In conclusion, we identified 17 new loci contributing to the genetic regulation of circulating 2 7 7 concentrations of cytokines. Improved understanding of the genetic basis of these inflammatory 2 7 8 markers will help to clarify the causal roles of cytokine signaling and upstream inflammation in humans. In addition, we identified a potential novel drug target for treatment of Behcet's disease molecular regulation of the immune system in health and disease. available. In addition, gene expression data from 1,664 participants of the 2011 follow-up were 2 9 7
analyzed for the present study. All participants gave written informed consent and the study was Bio-Plex 6.0 software 44 . The assays were performed according to manufacturer's instructions, 3 1 3 except, that the amount of beads, detection antibodies and streptavidin-phycoerythrin conjugate 3 1 4
were used with 50% lower concentrations than recommended. Only measures within the cytokine- were excluded (7 out of 48). In FINRISK1997, a total of 17 cytokines overlapped with those measured in FINRISK2002 and Subjects whose cytokine concentration were below or above of laboratory analysis detection limits 3 2 5
were omitted from the analyses. Cytokine distributions were first normalized with inverse 3 2 6
transformation. The transformed phenotypes were then adjusted for age, sex, body mass index and the identified loci. The proportion of total variance explained by independent SNPs was calculated 3 4 7 by following formula:
where β is the regression coefficient and MAF is minor allele frequency 48 .
3 5 0
Instrumental variable analysis of the VEGF cascade effects were performed with two-stage least 3 5 1 squares regression using ivreg from the R-package AER 17 . A weighted gene score based on the sum 3 5 2 of cytokine-increasing alleles of the two independent variants associated with VEGF (rs6921438 and the ten first genetic principal components. Gene expression data from peripheral blood leukocytes were available from 1,664 participants from Linear regression with probe as a dependent variable was used to test associations between To assess whether cytokine concentration could contribute to disease pathogenesis, we searched the SNPs 20 . The catalogue was downloaded on July 6, 2015 and catalogue SNPs with P<5×10 -8 were 3 7 8
selected for further analyses. The statistical significance for SNP-cytokine association was inferred 3 7 9
at P < 1.2×10 -9 . Tuberculosis Foundation (T.L.); Emil Aaltonen Foundation; and Yrjö Jahnsson Foundation. PW Finnish Foundation for Cardiovascular Research. We gratefully acknowledge Ville Aalto and Irina Lisinen for the expert technical assistance in the 3 9 2 data management. protein-1 (MCP-1) levels in Hispanic children. Cytokine 60, 634-638 (2012) . chemokine receptor. Science 261, 1182-4 (1993) . inference in epidemiological studies. Hum. Mol. Genet. 23, R89-98 (2014) . Behçet's disease and epistasis between HLA-B*51 and ERAP1. Nat. Genet. 45, 202-7 4 9 0 (2013). Mendelian randomisation analysis. lancet. Diabetes Endocrinol. 3, 243-53 (2015) . One 10, e0118149 (2015). emphysema. OMICS 17, 619-26 (2013) . sclerosis patients. Acta Neurol. Scand. 130, 46-52 (2014) . HLA haplotype specific manner assessed mainly by DRB1*03 and DRB1*04 haplotypes.
3 8
Genes Immun. 7, 130-40 (2006) . mediators. Blood 115, 5289-99 (2010) . Epidemiol. 37, 1220-6 (2008). Predicts Long-Term Risk of Severe Infection. Cell Syst. 1, 293-301 (2015) . genome-wide association studies by imputation of genotypes. Nat. Genet. 39, 906-13 (2007) . Rev. Genet. 11, 499-511 (2010) . 1.36×10 -3 The same locus is occasionally associated with more than one cytokine but only the strongest trait-association is reported in the table. Allele 2 is the effect allele. Beta and SE are in SD-units. All positions refer to human genome build 37. Info column reports the imputation quality metric calculated by the Impute2 software. HetPVal reports the effect size heterogeneity statistics between the cohorts. Expression BeadChip. * = The SNP is associated with cytokine concentration and with mRNA coding the cytokine. CTACK is also known as IL11RA and stem cell growth factor beta (SCGFb) as CLEC11A. for the number of cytokines tested in the study.
Figure 2
SNPs genome-widely associated with more than one cytokine. Variant rs12075-A is associated with increased concentrations of eotaxin, monocyte chemotactic protein-1 (MCP1) and growth regulated oncogene-α (GROa). In addition, rs12075-A is associated with increased DARC mRNA. Since DARC is a cell surface receptor, the cluster effect on the three cytokines is unlikely to be mediated (in a cascade) through any of the three cytokines associated with rs12075 (Panel a).
Similarly, effect of rs2228467 is mediated through a cell surface receptor (CCBP2) (Panel b). 
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